Multus Biotechnology Patents – Insights & Stats (Updated 2023)

Multus Biotechnology has a total of 4 patents globally, out of which no patents have been granted. Of these 4 patents, all patents are active. United Kingdom is where Multus Biotechnology has filed the maximum number of patents. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of Multus Biotechnology.

Multus Biotechnology was founded in the year 2019. The Company enables cultivated meat companies to scale affordably and profitably. They take care of the growth media, so its customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach they can design a completely animal-free growth media that is tailored for animal cells.

Do read about some of the most popular patents of Multus Biotechnology which have been covered by us in this article and also you can find Multus Biotechnology patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Multus Biotechnology patent portfolio.

How many patents does the founder and the CEO of Multus Biotechnology have?

The founder and CEO Cai Linton has 0 patent.

How many patents does Multus Biotechnology have?

Multus Biotechnology has a total of 4 patents globally. These patents belong to none of the unique patent families. Out of 4 patents, all patents are active.

How Many Patents did Multus Biotechnology File Every Year?

The company has 4 patents and correspondingly the filing year is 2022.

How many Multus Biotechnology patents are Alive/Dead?

All the Patents were filed by Multus Biotechnology are Alive.

How Many Patents did Multus Biotechnology File in Different Countries?

All the Patents were filed by Multus Biotechnology in the United Kingdom.

Where are Research Centres of Multus Biotechnology Patents Located?

The Research Centre for all the Multus Biotechnology patents is the United States of America.

List of Multus Biotechnology Patents

MULTUS Biotechnology PatentsTitle
GB202218985D0Engineered Epidermal Growth Factor Variants
GB202218987D0Engineered Platelet-Derived Growth Factor Variants
GB202203412D0Engineered Fibroblast Growth Factor Variants
GB202203414D0Recombinant Transforming Growth Factor Beta 3 In Yeast

What are Multus Biotechnology key innovation segments?

What Technologies are Covered by Multus Biotechnology?

The chart below distributes patents filed by Multus Biotechnology in different countries on the basis of the technology protected in patents. It also represents the markets where Multus Biotechnology thinks it’s important to protect particular technology inventions.

R&D Focus: How has Multus Biotechnology search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Multus Biotechnology?

Related Articles

Gripple Patents – Insights & Stats (Updated 2024)

Gripple has a total of 2125 patents globally, out of which 1264 have been granted. Of these 2125 patents, more than 61% patents are active. United Kingdom is where Gripple has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, United Kingdom seems

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.